Affymax, Inc. ADR (AFFY1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
4
19200 STEVENS CREEK BOULEVARD, SUITE 240, CUPERTINO, CA 94014
650-812-8700

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 1.862 Million Shares Outstanding74.49 Million Avg 30-day Volume 50.385 Thousand
P/E Ratio8.5594 Dividend Yield0.0 EPS0.15
Price to Revenue624.8333 Debt to Equity0.0 EBITDA3.208 Million
Price to Book Value5.076 Operating Margin-12130.9524 Enterprise Value22.844 Million
Current Ratio20.813 EPS Growth2.586 Quick Ratio15.883
1 Yr BETA 0.0 52-week High/Low 0.0 / Profit Margin7300.0
Operating Cash Flow Growth92.1684 Altman Z-Score-67.2097 Free Cash Flow to Firm -18.181 Million
View SEC Filings from AFFY1 instead.

View recent insider trading info

Funds Holding AFFY1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AFFY1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WALKER JOHN PETER

  • Director
0 2013-08-28 0

BRENNER RICHARD M CHIEF EXECUTIVE OFFICER

  • Officer
0 2013-07-02 0

ORWIN JOHN A

  • Director
76,666 2013-06-27 0

THOMPSON MARK G CHIEF FINANCIAL OFFICER

  • Officer
0 2013-06-06 0

ROSE J. WESTON PRESIDENT

  • Officer
0 2013-06-06 0

KNAPP JEFFREY H CHIEF COMMERCIAL OFFICER

  • Officer
18,125 2013-02-15 0

CROSS HERB CHIEF FINANCIAL OFFICER

  • Officer
21,370 2013-01-30 0

DULIEGE ANNE-MARIE CHIEF MEDICAL OFFICER

  • Officer
28,125 2013-01-30 0

LAPORTE KATHLEEN

  • Director
0 2012-12-14 0

VENTEICHER ROBERT SVP, TECHNICAL OPERATIONS

  • Officer
24,994 2012-11-23 0

WALKER KARIN L VP, FINANCE & CAO

  • Officer
0 2012-10-02 0

RENTON HOLLINGS

  • Director
0 2012-06-13 0

LOVE TED W

  • Director
0 2012-06-13 0

SPIEGELMAN DANIEL K

  • Director
0 2012-06-13 0

LEONARD KEITH R

  • Director
0 2012-06-13 0

VAN HEEK CHRISTI

  • Director
0 2012-06-13 0

MORRIS ARLENE CEO

  • Officer
  • Director
75,000 2010-09-22 0

CLEVELAND PAUL B EVP, CORP. DEVELOPMENT AND CFO

  • Officer
30,000 2010-09-22 0

CREDIT SUISSE AG/

  • 10% Owner
No longer subject to file 2010-08-09 0

DOUGLAS R LEE

  • Director
0 2010-05-24 0

LOVE STEVEN VICE PRESIDENT, FINANCE

  • Officer
0 2010-05-04 0

APAX PARTNERS EUROPE MANAGERS LTD

APAX EUROPE V GP CO.LTD

  • 10% Owner
1,031,355 2009-09-16 0

APAX MANAGERS INC

  • 10% Owner
790,871 2009-09-16 0

GALAKATOS NICHOLAS

  • Director
  • 10% Owner
0 2009-05-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AFFYMAX INC AFFY 2021-10-15 22:15:04 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 21:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 21:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 20:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 20:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 19:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 19:15:04 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 18:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 18:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 17:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 17:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 16:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 16:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 15:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 15:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 14:45:02 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 14:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 13:45:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 13:15:03 UTC -3.4322 3.5022 150000
AFFYMAX INC AFFY 2021-10-15 12:45:03 UTC -3.4322 3.5022 150000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments